Trial intelligence / Profile preview

Alfentanil combined with ciprofol to improve patients' satisfaction in gastrointestinal endoscopy

ChiCTR2100049601Phase 4Not yet recruiting

Sponsor
Gansu Provincial People's Hospital
Start
Sep 2021
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in gastrointestinal conditions comparing Alfentanil + ciprofol with Saline + ciprofol (2 arms). Primary endpoint: patients' satisfaction. Planned start Sep 2021; status: not yet recruiting.

02

Drugs

alfentanilciprofol
03

Conditions

gastrointestinal conditions

Beyond the preview

Go deeper on ChiCTR2100049601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100049601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call